Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Interactions Between Total Nucleated and CD34 Cell Dose and Their Impact on Outcomes After Single and Double Unrelated Cord Blood Transplantation for Patients with Hematological Malignancies. An Analysis on Behalf of Societe' Française De Greffe De Moelle Et Therapie Cellulaire (SFGM-TC) and Eurocord

Mauricette Michallet, Renato L.G. Cunha, Gérard Michel, Gérard Socié, Mohamad Mohty, Bernard Rio, MD, Didier Blaise, MD, Anne Sirvent, MD, Reza Tabrizzi, Pierre Bordigoni, Eric Deconinck, Ibrahim Yakoubagha, Jean-François Rossi, Natacha Maillard, Mohamad Sobh, Federico Garnier, MD, Annalisa Ruggeri, MD, Eliane Gluckman, MD, Vanderson Rocha, MD, PhD

Blood (2010) 116 (21): 361.

https://doi.org/10.1182/blood.V116.21.361.361

Published: 2010

Journal Articles

Inhibition of HIF1A Signaling by a Novel Class of Sulfonanilides for Targeted Treatment of Multiple Myeloma.

Dirk Hose, Anja Seckinger, Hartmut Goldschmidt, Tobias Meiβner, Blanka Rebacz, Jerome Moreaux, Vladimir Benes, Kai Neben, Jens Hillengass, Uta Bertsch, Anna Jauch, Jean François Rossi, Thomas Möhler, Jürgen Zimmermann, Christof von Kalle, Joe Lewis, Bernard Klein, Christoph Schultes

Blood (2009) 114 (22): 2856.

https://doi.org/10.1182/blood.V114.22.2856.2856

Published: 2009

Journal Articles

Mobilization of Plasma Cells in Healthy Individuals Treated with G-CSF for Hematopoietic Stem Collection.

Anouk Caraux, Marion Larroque, Christophe Duperray, Zhao-Yang Lu, Jean-François Rossi, MD, PhD, Bernard Klein

Blood (2009) 114 (22): 3679.

https://doi.org/10.1182/blood.V114.22.3679.3679

Published: 2009

Journal Articles

Prospective Multicenter Study for Evaluating Cognitive Disorders in Hematology-Oncology: A Pilot Study of 118 Patients

Jean François Rossi, Laurence Laurier, III, Jean-Louis Misset, Dominique Spaeth, F. Uwer, Pierre Soubeyran, Remy Largiller, Jean-Philippe Metges, Jean- Yves Blay, Michel Attal, Thierry Facon, Olivier Hermine, Roland Bugat, Jean-Philippe Spano, Laurent Cals, Hervé Cure, Dan Atlan, Mario Gjoklaj

Blood (2008) 112 (11): 1309.

https://doi.org/10.1182/blood.V112.11.1309.1309

Published: 2008

Journal Articles

Bone Morphogenic Protein 6: A Prognostic Factor Expressed by Normal Plasma Cells and Multiple Myeloma Cells Inhibiting Their Proliferation and Angiogenesis Induction

Anja Seckinger, Tobias Meißner, Jérôme Moreaux, Hartmut Goldschmidt, Axel Benner, Michael Hundemer, Thierry Rème, John D. Shaughnessy, Jr., Bart Barlogie, Uta Bertsch, Jens Hillengass, Anthony D. Ho, Véronique Pantesco, Anna Jauch, John De Vos, Jean François Rossi, Thomas Möhler, Bernard Klein, Dirk Hose

Blood (2008) 112 (11): 2701.

https://doi.org/10.1182/blood.V112.11.2701.2701

Published: 2008

Journal Articles

Osteoclast Gene Expression Profiling in Multiple Myeloma

Jerome Moreaux, Dirk Hose, Thierry Rème, Philippe Moine, Karène Mahtouk, Marion Moos, Guilhem Requirand, John De Vos, PhD, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2008) 112 (11): 2735.

https://doi.org/10.1182/blood.V112.11.2735.2735

Published: 2008

Journal Articles

Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma

Blood (2008) 112 (11): 248.

https://doi.org/10.1182/blood.V112.11.248.248

Published: 2008

Journal Articles

Phase I Study of IPH1101 (with Low Dose of IL-2) in Patient with B-NHL

Jean François Rossi, MD, PhD, Valerie Rouillé, Sylvie Lafaye de Micheaux, MD, Hélène Sicard, PhD, Olivier Pétricoul, PhD, Lucile Beautier, Christine d’Arnoux, MD, Volker Kunzmann, MD, PhD

Blood (2008) 112 (11): 5011.

https://doi.org/10.1182/blood.V112.11.5011.5011

Published: 2008

Journal Articles

A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of Vã9Vä2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data.

Guy Laurent, MD, PhD, Jean François Rossi, MD, PhD, Eric W Van Den Neste, MD, PhD, Fabien Audibert, Hervé Ghesquières, MD, Steven Le Gouill, MD, PhD, Pierre Feugier, MD, Helene Sicard, PhD, Sophie Ingoure, Elodie Soule, Sylvie Lafaye de Micheaux, MD

Blood (2008) 112 (11): 1002.

https://doi.org/10.1182/blood.V112.11.1002.1002

Published: 2008

Journal Articles

A Gene Expression Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma.

Dirk Hose, Thierry Rème, Thomas Hielscher, Jérôme Moreaux, Tobias Meißner, Anja Seckinger, Axel Benner, Michael Hundemer, John Shaughnessy, Jr., Bart Barlogie, Jens Hillengass, Uta Bertsch, Anna Jauch, Jean François Rossi, Thomas Möhler, Bernard Klein, Hartmut Goldschmidt

Blood (2008) 112 (11): 1667.

https://doi.org/10.1182/blood.V112.11.1667.1667

Published: 2008

Journal Articles

High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation (auto-SCT) Versus CHOP Regimen in Patients with Untreated Aggressive Non-Hodgkin’s Lymphoma: An Update of the GOELAMS 072 Trial with a Median Follow-up of 9.8 Years

Thomas Gastinne, Gandhi Damaj, Thierry Lamy, PhD, Norbert Ifrah, Eric Deconinck, Remy Gressin, MD, Philippe Colombat, MD, PhD, Vincent Delwail, Christian Berthou, Jean François Rossi, Jean Luc Harousseau, Noel-Jean Milpied, PhD

Blood (2008) 112 (11): 770.

https://doi.org/10.1182/blood.V112.11.770.770

Published: 2008

Journal Articles

Carcinoembryonic-Antigen-Related Cell Adhesion Molecule (CEACAM) Expression on Multiple Myelomas Inhibits Their Recognition by Autologous Memory CD8 T Cells

Mathias Witzens-Harig, Dirk Hose, Michael Hundemer, Simone Jünger, Anthony D. Ho, Jean François Rossi, Kai Neben, Bernard Klein, Hartmut Goldschmidt, Philipp Beckhove

Blood (2008) 112 (11): 738.

https://doi.org/10.1182/blood.V112.11.738.738

Published: 2008

Journal Articles

Comparison of Immune Reconstitution after Umbilical Cord Blood (UCB) and Allogenic Peripheral Blood Stem Cell (APBSC) Transplantation in Patients with Advanced Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML).

Jean-Come Meniane, MD, Patrice Ceballos, MD, Maud Condomines, PhD, Jean-françois Eliaou, MD PhD, Nathalie Fegueux, MD, Bernard Klein, PhD, Jean-françois Rossi, MD PhD

Blood (2007) 110 (11): 5008.

https://doi.org/10.1182/blood.V110.11.5008.5008

Published: 2007

Journal Articles

Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.

Jerome Moreaux, PhD, Anne-Catherine Sprynski, Karene Mahtouk, PhD, Philippe Moine, Nicolas Robert, Jean-François Rossi, MD, PhD, Bernard Klein, PhD

Blood (2007) 110 (11): 3522.

https://doi.org/10.1182/blood.V110.11.3522.3522

Published: 2007

Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Blood (2006) 107 (4): 1292–1298.

https://doi.org/10.1182/blood-2005-04-1588

Published: 2006

Journal Articles

Regulatory and Activated T Cells in Stem Cell Autografts Collected by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony Stimulating Factor.

Maud Condomines, Philippe Quittet, Zhao-Yang Lu, Laure Nadal, Pascal Latry, Ernesto Lopez, Marion Baudard, Jean-François Rossi, Karin Tarte, Bernard Klein

Blood (2005) 106 (11): 5216.

https://doi.org/10.1182/blood.V106.11.5216.5216

Published: 2005

Journal Articles

Molecular Classification of Multiple Myeloma (MM) Based on Gene Expression Profiling (GEP) and Fluorescence In Situ Hybridisation (FISH) Is an Independent Predictor for Event Free Survival (EFS).

Blood (2005) 106 (11): 507.

https://doi.org/10.1182/blood.V106.11.507.507

Published: 2005

Journal Articles

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

Jerome Moreaux, Friedrich W. Cremer, Thierry Reme, Karene Mahtouk, Veronique Pantesco, John de Vos, Marion Moos, Nicolas Robert, Hartmut Goldschmidt, Jean-François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 3400.

https://doi.org/10.1182/blood.V106.11.3400.3400

Published: 2005

Journal Articles

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Jérôme Moreaux, Friedrich W. Cremer, Thierry Reme, Marc Raab, Karene Mahtouk, Philine Kaukel, Veronique Pantesco, John De Vos, Eric Jourdan, Anna Jauch, Eric Legouffe, Marion Moos, Genevieve Fiol, Hartmut Goldschmidt, Jean François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (3): 1021–1030.

https://doi.org/10.1182/blood-2004-11-4512

Published: 2005

Includes: Supplemental data

Journal Articles

Multiple Myeloma: Global Expression Profiling (GEP) Indicates Upregulation of the Ribosomal Machinery in Hyperdiploid Clones.

Friedrich W. Cremer, John De Vos, Dirk Hose, Jean François Rossi, Carina Ittrich, Thierry Rème, Axel Benner, Eric Jourdan, Marc S. Raab, Jelena Bila, Ann-Cathrin Theil, Sunitha Jonnakuty, Coral del Val, Marion Moos, Hartmut Goldschmidt, Bernard Klein, Anna Jauch

Blood (2004) 104 (11): 1421.

https://doi.org/10.1182/blood.V104.11.1421.1421

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Inhibition of HIF1A Signaling by a Novel Class of Sulfonanilides for Targeted Treatment of Multiple Myeloma.

Mobilization of Plasma Cells in Healthy Individuals Treated with G-CSF for Hematopoietic Stem Collection.

Prospective Multicenter Study for Evaluating Cognitive Disorders in Hematology-Oncology: A Pilot Study of 118 Patients

Bone Morphogenic Protein 6: A Prognostic Factor Expressed by Normal Plasma Cells and Multiple Myeloma Cells Inhibiting Their Proliferation and Angiogenesis Induction

Osteoclast Gene Expression Profiling in Multiple Myeloma

Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma

Phase I Study of IPH1101 (with Low Dose of IL-2) in Patient with B-NHL

A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of Vã9Vä2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data.

A Gene Expression Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma.

High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation (auto-SCT) Versus CHOP Regimen in Patients with Untreated Aggressive Non-Hodgkin’s Lymphoma: An Update of the GOELAMS 072 Trial with a Median Follow-up of 9.8 Years

Carcinoembryonic-Antigen-Related Cell Adhesion Molecule (CEACAM) Expression on Multiple Myelomas Inhibits Their Recognition by Autologous Memory CD8 T Cells

Comparison of Immune Reconstitution after Umbilical Cord Blood (UCB) and Allogenic Peripheral Blood Stem Cell (APBSC) Transplantation in Patients with Advanced Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML).

Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Regulatory and Activated T Cells in Stem Cell Autografts Collected by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony Stimulating Factor.

Molecular Classification of Multiple Myeloma (MM) Based on Gene Expression Profiling (GEP) and Fluorescence In Situ Hybridisation (FISH) Is an Independent Predictor for Event Free Survival (EFS).

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Multiple Myeloma: Global Expression Profiling (GEP) Indicates Upregulation of the Ribosomal Machinery in Hyperdiploid Clones.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only